NCT04446182: A trial that was reported late by University of Utah
This trial has reported, although it was 103 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT04446182 |
|---|---|
| Title | A Phase II Study of Itacitinib (INCB039110) and Extracorporeal Photopheresis (ECP) for First-Line Treatment in Chronic Graft Versus Host Disease (GVHD) |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Jan. 29, 2021 |
| Completion date | March 29, 2022 |
| Required reporting date | March 29, 2023, midnight |
| Actual reporting date | July 10, 2023 |
| Date last checked at ClinicalTrials.gov | Dec. 5, 2025 |
| Days late | 103 |